Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial

INTRODUCTION: Osteopontin (OPN) is a malignancy-associated glycoprotein that contributes functionally to tumor aggressiveness. In metastatic breast cancer, we previously demonstrated that elevated OPN in primary tumor and blood was associated with poor prognosis. METHODS: We measured OPN in plasma b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bramwell, Vivien HC, Tuck, Alan B, Chapman, Judith-Anne W, Anborgh, Pieter H, Postenka, Carl O, Al-Katib, Waleed, Shepherd, Lois E, Han, Lei, Wilson, Carolyn F, Pritchard, Kathleen I, Pollak, Michael N, Chambers, Ann F
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978736/
https://ncbi.nlm.nih.gov/pubmed/24451146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3600
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi